Cargando…
Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
Vivax malaria remains one of the most serious and neglected tropical diseases, with 132 to 391 million clinical cases per year and 2.5 billion people at risk of infection. A vaccine against Plasmodium vivax could have more impact than any other intervention, and the use of a vaccine targeting multip...
Autores principales: | Atcheson, Erwan, Bauza, Karolis, Salman, Ahmed M., Alves, Eduardo, Blight, Joshua, Viveros-Sandoval, Martha Eva, Janse, Chris J., Khan, Shahid M., Hill, Adrian V. S., Reyes-Sandoval, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105880/ https://www.ncbi.nlm.nih.gov/pubmed/29986894 http://dx.doi.org/10.1128/IAI.00114-18 |
Ejemplares similares
-
Tailoring a Combination Preerythrocytic Malaria Vaccine
por: Bauza, Karolis, et al.
Publicado: (2016) -
Efficacy of a Plasmodium vivax Malaria Vaccine Using ChAd63 and Modified Vaccinia Ankara Expressing Thrombospondin-Related Anonymous Protein as Assessed with Transgenic Plasmodium berghei Parasites
por: Bauza, Karolis, et al.
Publicado: (2014) -
Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
por: Alves, Eduardo, et al.
Publicado: (2017) -
Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from Plasmodium Infection in a Murine Model
por: Reeder, Sophia M., et al.
Publicado: (2021) -
Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
por: Longley, Rhea J., et al.
Publicado: (2017)